A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, T. Murray and M. J. Thun, “Cancer Statistics, 2008,” CA: A Cancer Journal for Clinicians, Vol. 58, No. 2, 2008, pp. 71-96. http://dx.doi.org/10.3322/CA. 2007.0010
 K. C. Chu, R. E. Tarone and H. P. Freeman, “Trends in Prostate Cancer Mortality among Black Men and White Men in the United States,” Cancer, Vol. 97, No. 6, 2003, pp. 1507-1516.
 A. W. Partin, M. W. Kattan, E. N. Subong, P. C. Walsh, K. J. Wojno, J. E. Oesterling, et al., “Combination of Prostate-Specific Antigen, Clinical Stage, and Gleason Score to Predict Pathological Stage of Localized Prostate Cancer. A Multi-Institutional Update,” JAMA, Vol. 277, No. 18, 1997, p. 1445. http://dx.doi.org/10.1001/jama.1997.03540420041027
 A. Van Hoffen, A. S. Balajee, A. A. van Zeeland and L. H. Mullenders, “Nucleotide Excision Repair and Its Interplay with Transcription,” Toxicology, Vol. 193, No. 1-2, 2003, pp. 79-90.
 Y. Kubotta, R. A. Nash, A. Klungland, et al., “Reconstitution of DNA Base Excision-Repair with Purified Human Proteins: Interaction between DNA Polymerase Beta and the XRCC1 Protein,” The EMBO Journal, Vol. 15, No. 23, 1996, pp. 6662-6670.
 D. M. Parkin, F. Bray, P. Ferlay and P. Pisani, “Global Cancer Statistics,” CA: A Cancer Journal for Clinicians, Vol. 55, No. 2, 2005, pp. 74-108. http://dx.doi.org/10.3322/canjclin.55.2.74
 L. Li, C. Peterson and R. Legerski, “Sequence of the Mouse XPC cDNA and Genomic Structure of the Human XPC Gene,” Nucleic Acids Research, Vol. 24, No. 6, 1996, pp. 1026-1028.
 Y. Zhu, H. Yang, Q. Chen, J. Lin, H. B. Grossman, C. P. Dinney, X. Wu and J. Gu, “Modulation of DNA Damage/DNA Repair Capacity by XPC Polymorphisms,” DNA Repair (Amst), Vol. 7, No. 2, 2008, pp. 141-148. http://dx.doi.org/10.1016/j.dnarep.2007.08.006
 S. I. Berndt, E. A. Platz, M. D. Fallin, L. W. Thuita, S. C. Hoffman and K. J. Helzlsouer, “Genetic Variation in the Nucleotide Excision Repair Pathway and Colorectal Cancer Risk,” Cancer Epidemiology, Biomarkers & Prevention, Vol. 15, No. 11, 2006, pp. 2263-2269.
 H. Shen, E. M. Sturgis, S. G. Khan, Y. Qiao, T. Shahlavi, S. A. Eicher, Y. Xu, X. Wang, S. S. Strom, M. R. Spitz, K. H. Kraemer and Q. Wei, “An Intronic Poly (AT) Polymorphism of the DNA Repair Gene XPC and Risk of Squamous Cell Carcinoma of the Head and Neck: A Case-Control Study,” Cancer Research, Vol. 61, 2001, pp. 3321-3325.
 S. Sanyal, F. Festa, S. Sakano, Z. Zhang, G. Steineck, U. Norming, H. Wijkstr?m, P. Larsson, R. Kumar and K. Hemminki, “Polymorphisms in DNA Repair and Metabolic Genes in Bladder Cancer,” Carcinogenesis, Vol. 25, No. 5, 2004, pp. 729-734. http://dx.doi.org/10.1093/carcin/bgh058
 L. Fontana, R. Bosviel, L. Delort, L. Guy, N. Chalabi, F. Kwiatkowski, S. Satih, N. Rabiau, J. P. Boiteux, A. Chamoux, Y. J. Bignon and D. J. Bernard-Gallon, “DNA Repair Gene ERCC2, XPC, XRCC1, XRCC3 Polymorphisms and Associations with Bladder Cancer Risk in a French Cohort,” Anticancer Research, Vol. 28, No. 1, 2008, pp. 1853-1856.
 A. E. Vidal, S. Boiteux, I. D. Hickson, et al., “XRCC1 Coordinates the Initial and Late Stages of DNA Abasic Site Repair through Protein-Protein Interactions,” The EMBO Journal, Vol. 20, No. 22, 2001, pp. 6530-6539. http://dx.doi.org/10.1093/emboj/20.22.6530
 J. D. Ritchey, W. Y. Huang, A. P. Chokkalingam, et al., “Genetic Variants of DNA Repair Genes and Prostate Cancer: A Population-Based Study,” Cancer Epidemiology, Biomarkers & Prevention, Vol. 14, No. 7, 2005, pp. 1703-1709. http://dx.doi.org/10.1158/1055-9965.EPI-04-0809
 G. H. van Gils, R. M. Bostick, M. C. Stern, et al., “Differences in Base Excision Repair Capacity May Modulate the Effect of Dietary Antioxidant Intake on Prostate Cancer Risk: An Example of Polymorphisms in the XRCC1 Gene,” Cancer Epidemiology, Biomarkers & Prevention, Vol. 11, No. 11, 2002, pp. 1279-1284.
 B. A. Rybicki, D. V. Conti, A. Moreira, et al., “DNA Repair Gene XRCC1 and XPD Polymorphism and Risk of Prostate Cancer,” Cancer Epidemiology, Biomarkers & Prevention, Vol. 13, No. 1, 2004, pp. 23-29. http://dx.doi.org/10.1158/1055-9965.EPI-03-0053
 L. Chen, C. B. Ambrosone, J. Lee, et al., “Association between Polymorphisms in the DNA Repair Genes XRCC1 and APEX1, and the Risk of Prostate Cancer in White and Black Americans,” Journal of Urology, Vol. 175, No. 1, 2006, pp. 108-112. http://dx.doi.org/10.1016/S0022-5347(05)00042-X
 Z. Xu, L. X. Hua, L. X. Qian, et al., “Relationship between XRCC1 Polymorphisms and Susceptibility to Prostate Cancer in Men from Han, Southern China,” Asian Journal of Andrology, Vol. 9, No. 3, 2007, pp. 331-338. http://dx.doi.org/10.1111/j.1745-7262.2007.00263.x
 H. Hirata, Y. Hinoda, Y. Tanaka, N. Okayama, Y. Suehiro, K. Kawamoto, N. Kikuno, S. Majid, K. Vejdani and R. Dahiya, “Polymorphisma of DNA Repair Genes Are Risk Factors for Prostate Cancer,” European Journal of Cancer, Vol. 43, No. 2, 2007, pp. 231-237. http://dx.doi.org/10.1016/j.ejca.2006.11.005